Stroke AI Market

The stroke AI market is projected to reach USD 1.60 billion by 2030 from USD 0.32 billion in 2025, at a CAGR of 38.4% during the forecast period. The global stroke AI market is growing steadily, driven by the need to improve stroke outcomes through faster diagnosis and treatment decisions. Stroke remains a major public health challenge, with more than 795,000 people experiencing a stroke every year in the US (Source: US CDC). The stroke death rate in 2022 was 39.5 per 100,000 people, and in 2023 it was 39.0 per 100,000 people. Approximately 87% of all strokes are ischemic in nature, occurring when blood flow to the brain is obstructed, most commonly due to a thrombus or embolus. AI-powered tools that rapidly analyze CT and MRI scans for ischemic and hemorrhagic stroke are increasingly supporting faster diagnosis and treatment. For example, Viz.ai automatically detects critical findings on imaging and alerts care teams, reducing time-to-treatment and driving adoption across hospitals globally.

Some of the major players in the stroke AI market with significant global presence include Siemens Healthineers AG (Germany), Canon Medical Systems Corporation (Japan), Aidoc (US), RapidAI (US), Brainomix (UK), and Viz.ai, Inc. (US), among others. These players have incorporated various organic and inorganic strategies, including collaborations, acquisitions, product launches, partnerships, agreements, and expansions, to strengthen their international footprint and capture a greater share of the stroke AI market. These organic and inorganic strategies have allowed the market to expand across geographies by offering coding solutions.

To know about the assumptions considered for the study download the pdf brochure

In December 2025, Aidoc (US) partnered with Cercare Medical (Denmark) and Circle CVI (Canada) to add their advanced imaging AI tools to Aidoc’s platform, enhancing stroke assessment and workflow efficiency.
In April 2025, Brainomix (UK) received FDA clearance for an enhanced capability in its Brainomix 360 Stroke platform that automatically measures ischemic core volume from standard non-contrast CT scans.

Siemens Healthineers AG (Germany) offers stroke AI solutions designed to enhance acute neurovascular diagnosis, accelerate clinical workflows, and support treatment decisions. Its AI-enabled software integrates with advanced imaging modalities such as CT and MRI to provide automated tools for ischemic stroke assessment, including ASPECTS scoring, perfusion analysis, and vessel occlusion detection, through technologies like Recon&GO Inline ASPECTS and AI-assisted post-processing within their imaging platforms. The company has a wide range of geographic presence across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Aidoc (US) provides advanced, AI-powered medical imaging solutions that support rapid triage and diagnosis in acute stroke care. Its aiOS platform integrates a suite of deep-learning algorithms that automatically analyze CT and CT angiography scans to detect critical findings such as intracranial hemorrhage (ICH), large vessel occlusions (LVO), and early ischemic changes. The company delivers real-time alerts and prioritizes urgent cases within radiology workflows. Aidoc’s stroke AI solutions help clinicians accelerate interpretation, reduce time-to-treatment, and improve patient outcomes in emergency and neurovascular settings.

MARKET RANKING

The competitive landscape of the stroke AI market is led by five major companies: Siemens Healthineers AG (Germany), Viz.ai, Inc. (US), Canon Medical Systems Corporation (Japan), RapidAI (US), and Aidoc (US), shaping market evolution through differentiated strategies and sustained technology investment. Siemens Healthineers and Canon Medical integrate AI-enabled stroke analysis (such as ASPECTS scoring, perfusion analysis) directly into their CT and MRI platforms. Viz.ai and RapidAI specialize in AI-driven detection and triage of acute stroke conditions, including large vessel occlusion (LVO), hemorrhage, and perfusion deficits. Aidoc delivers AI-based radiology triage through its platform, automatically flagging critical neurovascular findings to prioritize urgent stroke cases.

Related Reports:

Stroke AI Market by Offering (Software, [AI], Services), Classification (ICD, CPT, HCPCS), Specialty (Surgical, Radiology), Function (Code, Assignment, Reimbursement, Analytics, Denial, Audit), End User (Hospital, ASC, Payers) - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com